GLA and Fabry disease: At the beginning of the 1970s, FD was known as an inborn glycosphingolipid catabolism defect, causing its accumulation principally in the fibromuscular cells in the vessel wall, together with a decrease in alpha-galactosidase plasma levels [1,2].